How should I taper trazodone after completing a lorazepam taper in a patient taking buspirone 5 mg three times daily, trazodone 50 mg twice daily, mirtazapine at bedtime, and lorazepam 0.25 mg daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trazodone Tapering After Benzodiazepine Discontinuation

After completing your lorazepam taper, you should taper trazodone very slowly using a hyperbolic (proportionate) reduction schedule, decreasing by approximately 10% of the current dose every 2-4 weeks, rather than stopping abruptly or using fixed linear reductions.

Why Gradual Tapering Matters

Trazodone, despite being commonly perceived as "safer" than benzodiazepines, can produce withdrawal symptoms when discontinued—even at therapeutic doses 1. The mechanism involves serotonergic system effects and noradrenergic rebound, compounded by trazodone's relatively short half-life 1. Abrupt discontinuation should be avoided; the medication should be tapered at a very slow rate 1.

Recommended Tapering Approach

Starting Point

  • Begin trazodone taper only after you have successfully completed the lorazepam discontinuation and stabilized (typically 2-4 weeks post-benzodiazepine) 2, 3
  • Your current dose: 50 mg twice daily (100 mg total daily)

Tapering Schedule

Use hyperbolic (proportionate) reductions:

  • Reduce by 10% of the most recent dose every 2-4 weeks 3, 4
  • This means progressively smaller absolute dose reductions as you go lower
  • Example progression from 100 mg daily:
    • 100 mg → 90 mg (reduce 10 mg)
    • 90 mg → 81 mg (reduce 9 mg)
    • 81 mg → 73 mg (reduce 8 mg)
    • Continue this pattern

Why not linear reductions? Linear cuts (e.g., 25 mg every week) produce increasingly large pharmacological changes at lower doses, escalating withdrawal symptoms 5. The relationship between dose and receptor activity is hyperbolic—small dose changes at low levels create disproportionately large effects 5.

Practical Implementation

Since trazodone comes in 50 mg tablets, you'll need:

  • Liquid formulation or compounded preparations to achieve precise small reductions, especially below 25 mg 3, 6
  • Split doses appropriately (e.g., if taking 90 mg daily, this might be 50 mg at bedtime and 40 mg earlier)

Managing the Taper

Monitoring and Adjustments

  • If withdrawal symptoms emerge (anxiety, insomnia, agitation, mood changes): pause the taper or return to the previous tolerated dose 3, 4
  • Wait until symptoms resolve before attempting further reductions
  • Slow down if needed—some patients require months to years for complete discontinuation 4

Your Concurrent Medications

You're also taking:

  • Buspirone 5 mg three times daily: Continue unchanged; this provides non-benzodiazepine anxiolytic support
  • Mirtazapine at bedtime: Continue unchanged; this addresses sleep and has different mechanisms than trazodone

These medications may actually facilitate your trazodone taper by providing alternative coverage for anxiety and sleep 2.

Critical Warnings

Withdrawal Symptoms to Watch For

  • Anxiety, insomnia, agitation
  • Mood changes, irritability
  • Physical symptoms: headache, dizziness, nausea
  • Rebound of original symptoms

When to Pause or Reverse

  • Clinically significant withdrawal symptoms signal the need to slow the taper 4
  • Don't push through severe symptoms—this risks protracted withdrawal
  • Reverting to a previous dose is appropriate if distress occurs 6

Timeline Expectations

Realistic timeframe: 6-12+ months for complete discontinuation from 100 mg daily

  • This is not a sprint—slower is safer 7
  • The final doses (below 10-15 mg) will require the smallest incremental reductions and may take longest 5
  • Some patients successfully taper to very low doses (equivalent to 5 mg or less) before final discontinuation 5

Evidence Quality Note

The strongest evidence supports gradual tapering principles from benzodiazepine literature 3, 4, which applies to other CNS-active medications. Direct trazodone tapering data is limited 1, but the available evidence consistently warns against rapid discontinuation. One small study showed trazodone could be reduced from 300 mg to 185 mg over one year in benzodiazepine-dependent patients without abuse 8, but this involved patients already on trazodone for benzodiazepine withdrawal—a different clinical scenario.

The 2008 insomnia guideline explicitly states: "discontinuing an antidepressant over 10 to 14 days limits withdrawal symptoms" 2—but this applies to standard therapeutic courses, not your situation of concurrent polypharmacy and recent benzodiazepine discontinuation where slower tapering is prudent.

Practical Algorithm

  1. Wait 2-4 weeks after last lorazepam dose
  2. Obtain liquid trazodone or arrange compounding
  3. Calculate 10% reduction from current dose
  4. Implement reduction and monitor for 2-4 weeks
  5. If tolerated: proceed to next 10% reduction
  6. If withdrawal emerges: pause or increase back to previous dose
  7. Repeat until reaching very low doses (5-10 mg range)
  8. Final discontinuation: extend interval between doses before stopping completely 4

References

Research

Mechanisms of the development of trazodone withdrawal symptoms.

International clinical psychopharmacology, 1994

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Benzodiazepine Tapering: A Marathon, Not a Sprint.

Journal of addiction medicine, 2026

Research

Trazodone in benzodiazepine dependence.

The Journal of clinical psychiatry, 1993

Related Questions

Is a taper schedule of reducing diazepam from 30 mg daily to 25 mg for two weeks and then to 20 mg for the next two weeks an appropriate first‑month taper for a patient taking 30 mg daily?
What is the recommended tapering schedule for discontinuing trazodone (antidepressant) from a dose of 100 milligrams?
Is it safe to taper clonazepam from 2 mg daily to 0.5 mg three times a day after two weeks of use?
What is the recommended protocol for tapering off trazodone (antidepressant)?
Does trazodone (antidepressant) require tapering after a short duration of use at a low dose?
In a patient with severe hypertension without target‑organ damage (hypertensive urgency), how rapidly should the blood pressure be lowered compared to a hypertensive emergency?
In streptococcal tonsillitis, can the exudate coalesce into larger patches and then be shed all at once?
Given that the patient is stable on buspirone 5 mg three times daily, trazodone 50 mg morning and afternoon, mirtazapine at bedtime, and lorazepam 0.25 mg in the morning, should we continue this regimen?
What is the most likely diagnosis and appropriate diagnostic and treatment plan for a patient with flat, thick white‑yellow tonsillar exudate, malaise, chills, fatigue, no fever, and a negative EBV test?
Which baseline laboratory tests are required before initiating ixekizumab (Taltz) and what monitoring schedule should be followed after starting therapy?
What is the recommended tapering schedule to discontinue lorazepam (0.25 mg daily) and trazodone (50 mg twice daily) while continuing buspirone (5 mg three times daily) and mirtazapine at night?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.